Lonza Group AG | Finanzwire

BRIEF

published on 12/12/2024 at 06:30, 9 days 7 hours ago

Lonza Unveils "One Lonza" Strategy and New Structure

Financial Outlook Organizational Change Lonza Strategy CDMO Focus Divestment Plans
PRESS RELEASE

published on 12/12/2024 at 06:25, 9 days 7 hours ago

Lonza Investor Update 2024 Outlines Strategy, New Organizational Structure and Guidance
Lonza Investor Update 2024 reveals 'One Lonza' strategy, new organizational structure, and financial guidance highlights for 2025 and beyond

CDMO Lonza Organizational Structure Investor Update One Lonza
BRIEF

published on 11/12/2024 at 07:05, 1 month 9 days ago

Lonza Expands Bioconjugation Capabilities in Switzerland

Sustainability Lonza ADCs Bioconjugation Visp Expansion
PRESS RELEASE

published on 11/12/2024 at 07:00, 1 month 9 days ago

Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites
Lonza announces expansion of bioconjugation capabilities in Visp (CH) with two new manufacturing suites, addressing market demand and offering expertise to a broad customer base

Expansion Manufacturing Lonza Bioconjugation Visp
BRIEF

published on 10/24/2024 at 07:05, 1 month 28 days ago

Lonza Group AG Confirms 2024 Outlook Amid Strategic Expansions

Manufacturing Expansion Lonza 2024 Outlook Genentech Acquisition CDMO Business Performance Vertex Agreement
PRESS RELEASE

published on 10/24/2024 at 07:00, 1 month 28 days ago

Q3 2024 Qualitative Update: Lonza Confirms Full-Year Outlook 2024
Lonza confirms Full-Year Outlook 2024 with flat year-on-year sales in CER and high 20s CORE EBITDA margin in Q3 performance update

Sales EBITDA Lonza Full-year Outlook Q3 Performance
BRIEF

published on 10/22/2024 at 07:05, 1 month 30 days ago

Lonza Extends Partnership for Antibody-Drug Conjugates Supply

Lonza Manufacturing Expansion ADCs Bioconjugation Pharmaceutical Partnership
PRESS RELEASE

published on 10/22/2024 at 07:00, 1 month 30 days ago

Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates
Lonza extends collaboration with major pharmaceutical partner for integrated commercial supply of antibody-drug conjugates, including construction of dedicated bioconjugation capacity in Visp, and commercial antibody manufacturing for new ADC therapy

Lonza ADCs Commercial Supply Bioconjugation Pharmaceutical Partner
BRIEF

published on 10/03/2024 at 09:05, 2 months 18 days ago

Lonza Nominates David Meline as Independent Board Member

Board Of Directors Annual General Meeting Financial Experience Lonza Group David Meline
PRESS RELEASE

published on 10/03/2024 at 09:00, 2 months 18 days ago

Lonza Nominates David Meline as Independent Board Member
Lonza nominates David Meline, experienced CFO, for Board position. Olivier Verscheure not to seek re-election. Details on David's background and Lonza's activities

CFO Lonza Board Member David Meline Olivier Verscheure

1 2 ... 6

Published on 12/21/2024 at 01:30, 12 hours 45 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 12 hours 45 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 14 hours 10 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 14 hours 15 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 14 hours 45 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 13 hours 23 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 13 hours 29 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 19 hours 4 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 19 hours 18 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 20 hours 14 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 1 hour 57 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 20 hours 15 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 20 hours 20 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 19 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News